Results 191 to 200 of about 491,510 (368)

A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapy

open access: yesCancer Communications
Yingqiang Liu   +13 more
doaj   +1 more source

Antitumor Activity of Thiosugars

open access: yesYAKUGAKU ZASSHI, 1967
Masuo Akagi   +6 more
openaire   +3 more sources

Near‐Infrared‐Driven Metal–Organic Frameworks‐Based Nanorobots for Controlled Photothermal‐Chemical Therapy Synergistic Induction of Cancer Cell Death

open access: yesAdvanced Robotics Research, EarlyView.
To achieve efficient cancer cell death, a bowl‐shaped PDA@UiO‐66@DOX nanorobot drug‐delivery nanoplatform was developed. Near‐infrared irradiation not only drives the nanorobot to exhibit self‐thermophoretic motion and elevates temperature but also triggers Doxorubicin (DOX) release via hyperthermia, enhancing cancer cells uptake of DOX and thereby ...
Tong Lin   +6 more
wiley   +1 more source

Activation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy improves antitumor response. [PDF]

open access: yesJ Immunother Cancer
Shim D   +8 more
europepmc   +1 more source

Proteomic Analysis of DNA−Protein Cross-Linking by Antitumor Nitrogen Mustards [PDF]

open access: bronze, 2010
Rachel Loeber   +5 more
openalex   +1 more source

Stromal‐Derived IL‐8 Promotes M2 Macrophage Polarization via the RhoA/MRTF‐A/SRF Transcriptional Axis to Impair CD8+ T Cell Cytotoxicity in Lung Cancer

open access: yesAdvanced Science, EarlyView.
In the recondite pulmonary neoplastic milieu, DESMIN+ cancer‐associated fibroblasts function as the paramount stromal source of IL‐8, precipitating a deleterious immunological metamorphosis by engaging CXCR2 receptors on the myeloid lineage. This paracrine stimulus triggers a mechanotransduction cascade characterized by RhoA‐dependent actin ...
Xuyu Gu   +7 more
wiley   +1 more source

Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs [PDF]

open access: yes
Zhuoya Deng,1– 3,* Yuying Tian,1,* Jing Wang,1 Yongru Xu,1 Zherui Liu,3,4 Zhaohui Xiao,1 Zhaohai Wang,1 Minggen Hu,1 Rong Liu,1 Penghui Yang1 1Faculty of Hepato-Pancreato-Biliary Surgery, Institute of Hepatobiliary Surgery, the First Medical ...
Liu Z   +9 more
core   +1 more source

Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions. [PDF]

open access: yesJ Immunother Cancer
Gujar S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy